Published in J Clin Invest on December 01, 1994
Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol (2004) 1.48
A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy. Am J Pathol (2004) 0.82
Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a). J Lipid Res (2008) 0.78
Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations. Arterioscler Thromb Vasc Biol (2012) 0.77
Lipoprotein(a)-clinical aspects and future challenges. Clin Res Cardiol Suppl (2015) 0.77
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study. J Hum Genet (2015) 0.76
Lipoprotein(a): A Historical Appraisal. J Lipid Res (2016) 0.75
Clinical Application of Genetic Testing in Heart Failure. Curr Heart Fail Rep (2017) 0.75
Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon. Am J Trop Med Hyg (2017) 0.75
A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res (1988) 7.28
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature (1987) 4.54
The mysteries of lipoprotein(a). Science (1989) 3.45
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest (1987) 2.35
Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest (1990) 2.16
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A (1987) 1.93
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest (1993) 1.69
Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68
Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest (1991) 1.68
Plasma lipid transfer proteins. J Lipid Res (1986) 1.56
Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry (1990) 1.51
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem (1992) 1.45
Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci U S A (1994) 1.42
Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A (1989) 1.34
Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res (1990) 1.33
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33
Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem (1993) 1.23
Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest (1983) 1.22
Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet (1991) 1.20
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest (1993) 1.17
The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis (1991) 1.15
Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem (1990) 1.14
Lp(a): an interloper into the fibrinolytic system? Thromb Haemost (1990) 1.11
Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. Eur J Biochem (1974) 1.09
Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations. Arterioscler Thromb (1991) 1.07
Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry (1991) 1.06
Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J Biol Chem (1991) 1.06
Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a]. Biophys J (1993) 1.02
Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro. Scand J Clin Lab Invest Suppl (1975) 1.01
Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun (1993) 1.00
Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest (1993) 0.96
Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. J Lipid Res (1990) 0.96
Substitution in vitro of lecithin-cholesterol acyltransferase. Analysis of changes in plasma lipoproteins. Eur J Biochem (1980) 0.92
Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet (1992) 0.92
Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res (1993) 0.91
Transferrinfection: a highly efficient way to express gene constructs in eukaryotic cells. Ann N Y Acad Sci (1992) 0.89
Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. Biochim Biophys Acta (1988) 0.89
Lipoprotein(a) in subjects with familial defective apolipoprotein B100. Atherosclerosis (1992) 0.88
Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an LP(a)-like complex. Biochemistry (1993) 0.86
Abnormalities in lipoproteins of d < 1.006 g/ml in familial lecithin:cholesterol acyltransferase deficiency. J Lipid Res (1980) 0.85
Familial lecithin:cholesterol acyltransferase deficiency--a clinical survey. Scand J Clin Lab Invest Suppl (1974) 0.83
Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice. Biochem J (1976) 0.82
Interaction of lipoprotein Lp[a] with the B/E-receptor: a study using isolated bovine adrenal cortex and human fibroblast receptors. J Lipid Res (1990) 0.80
Interaction of Lp(a) and of apo(a) with liver cells. Arterioscler Thromb (1993) 0.79
Action of lecithin-cholesterol acyltransferase on low-density lipoproteins in native pig plasma. Biochemistry (1987) 0.78
Lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes. Adv Exp Med Biol (1986) 0.77
The effect of genetic determinants of low density lipoprotein levels on lipoprotein (a). Clin Invest Med (1991) 0.76
An internet-accessible database of mouse developmental anatomy based on a systematic nomenclature. Mech Dev (1998) 7.02
Conserving large carnivores: dollars and fence. Ecol Lett (2013) 4.84
Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation (1968) 3.82
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest (1992) 2.80
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest (1995) 2.48
Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol (2000) 2.42
Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest (1976) 2.36
Transmission of glioblastoma multiforme through liver transplantation. Lancet (1998) 2.33
Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest (1995) 2.27
Volunteering for early phase gene transfer research in Parkinson disease. Neurology (2006) 2.27
Cloning and expression of human lecithin-cholesterol acyltransferase cDNA. Proc Natl Acad Sci U S A (1986) 2.27
Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09
Molecular characterization of phagosomes. J Biol Chem (1994) 2.07
[Host range and infection cycle of a newly isolated strain of Bdellovibrio bacteriovorus]. Arch Mikrobiol (1968) 1.94
Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa. Int J Tuberc Lung Dis (2002) 1.87
Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A (1997) 1.85
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology (2011) 1.83
Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation (2001) 1.77
Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J (1999) 1.72
The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett (1979) 1.70
Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab (1975) 1.62
In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int (2007) 1.61
Providing a complete online multimedia patient record. Proc AMIA Symp (1999) 1.60
Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol (1999) 1.58
Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis (1981) 1.54
Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I. Biochim Biophys Acta (1986) 1.53
Testicular torsion: late results with special regard to fertility and endocrine function. J Urol (1980) 1.52
Lipoprotein(a) in renal disease. Am J Kidney Dis (1996) 1.51
Use of a carotid artery for arterial cannulation: side-related differences. Thorac Cardiovasc Surg (2010) 1.51
Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma. J Biol Chem (1997) 1.49
Turnover of lipoprotein (a) in man. J Clin Invest (1980) 1.48
Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol (2000) 1.48
Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures. J Cell Sci (2000) 1.45
Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J Biol Chem (2001) 1.43
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia (1993) 1.42
Postprandial hyperlipemia inhibits platelet aggregation without affecting prostanoid metabolism. Prostaglandins Leukot Essent Fatty Acids (1989) 1.42
Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem (1980) 1.38
Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. J Mol Biol (1992) 1.35
Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology (2008) 1.35
Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity. J Lipid Res (1989) 1.35
Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A (1989) 1.34
A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. Am J Hum Genet (1999) 1.34
Antimalarials. 3. Benzothiazole amino alcohols. J Med Chem (1968) 1.33
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood (2001) 1.30
Submaximal stimulation of porcine endothelial cells causes focal Ca2+ elevation beneath the cell membrane. J Physiol (1998) 1.29
The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol (1999) 1.29
Suppressor cell function defect in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol (1979) 1.28
Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci U S A (1991) 1.25
In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes (2001) 1.25
Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab (1987) 1.24
Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. Mol Cell Biol (2001) 1.23
Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest (1983) 1.22
Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA (1981) 1.22
Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumers. Ann Nutr Metab (1982) 1.22
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
Iodide-induced thyrotoxicosis in Boston. N Engl J Med (1972) 1.18
Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis (1987) 1.18
Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab (1976) 1.18
Chimeric papillomavirus-like particles. Virology (1997) 1.17
Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb (1992) 1.17
Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet (1996) 1.17
Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem (2001) 1.16
Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol (2000) 1.14
Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. J Biol Chem (1990) 1.14
Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells. Br J Pharmacol (1999) 1.14
Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. Biochemistry (1999) 1.14
Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis (1988) 1.14
Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol Biomarkers Prev (2000) 1.14
Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest (1988) 1.13
Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. J Cancer Res Clin Oncol (2008) 1.13
A cadaver workshop to teach medical procedures. Med Educ (1986) 1.13
Plasma lipids and lipoproteins of a patient with cholesteryl ester storage disease. J Inherit Metab Dis (1985) 1.12
Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. Clin Chem (1976) 1.12
Determination of high-density lipoproteins: screening methods compared. Clin Chem (1979) 1.12
Thyroid hormones and the energetics of active sodium-potassium transport in mammalian skeletal muscles. J Physiol (1979) 1.12
Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest (1973) 1.12
Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest (2001) 1.11
Natural history of valvular aortic stenosis. Br Heart J (1973) 1.11
Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol (2001) 1.10
Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. Eur J Biochem (1974) 1.09
Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res Treat (1995) 1.09
Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res (2005) 1.09
Muscle-specific overexpression of human lipoprotein lipase in mice causes increased intracellular free fatty acids and induction of peroxisomal enzymes. Biochimie (1997) 1.07
Inducible NO synthase: role in cellular signalling. J Exp Biol (1999) 1.06
Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels. Proc Natl Acad Sci U S A (1999) 1.06
New fluorogenic triacylglycerol analogs as substrates for the determination and chiral discrimination of lipase activities. J Lipid Res (1996) 1.06
Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun (2000) 1.06
Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem (1989) 1.05
Adrenomedullary response to maximal stress in humans. Am J Med (1984) 1.04
The role of thyroid hormones in the control of energy expenditure. Clin Endocrinol Metab (1984) 1.04
Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme. Oncogene (2012) 1.04
High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes (1996) 1.03
Annexin V: the key to understanding ion selectivity and voltage regulation? Trends Biochem Sci (1994) 1.02
Central effects of sympathomimetic amines on the blood pressure. Eur J Pharmacol (1971) 1.02